Table 2 Patterns of tumor recurrence in the study participants.

From: Californium-252 neutron intracavity brachytherapy alone for T1N0 low-lying rectal adenocarcinoma: A definitive anal sphincter-preserving radiotherapy

  

n (%)

No

 

8 (87.5)

Yes

 

4 (12.5)

 

Local

1 (3.1)

 

Lung

1 (3.1)

 

Liver

2 (6.3)

Total

 

32 (100)